Among patients with drug-resistant epilepsy, frequent cannabis use may be associated with markers of increased epilepsy severity.

There is an increased risk for dementia associated with having a transient ischemic attack, underscoring the value of stroke prevention.

Dr Zayed Almadidy, MD utilizes TikTok to combat medical misinformation and educate the public about complex neuroscience topics.

Type 2 diabetes is linked to regional cortical thinning and faster cognitive decline in older adults without baseline cognitive impairment.

Initiating hormone replacement therapy near the onset of menopause may reduce the risk for LATE neuropathological changes in older women.

Inflammatory bowel disease is not associated with overall hypertensive disorders of pregnancy, but is associated with risk for preeclampsia.

Continuous activity monitoring with wearable devices reveals that daily step count patterns correlate with disability severity in progressive MS.

Later-life depression and limited education are significantly associated with an increased risk for dementia among American Indian adults.

Frailty is an independent risk factor for incident cognitive impairment among men with nondialysis chronic kidney disease.

A machine learning model utilizing longitudinal electronic diary data can accurately forecast the likelihood of next-day migraine attacks.

The FDA has approved Aqneursa (levacetylleucine) for ataxia in adult and pediatric patients with ataxia-telangiectasia weighing at least 15 kg.

FDA approves Juvmo (tavapadon), a selective D1/D5 receptor partial agonist, for Parkinson disease based on phase 3 TEMPO trial data.